Clinical trial · Observational
Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling
Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Including DCE-MRI Based on Incoherent Undersampling
NCT02944006CI-TRIAL-00055576unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to establish radiomics database for pancreas cancer from multiparametric MRI including DCE-MRI obtained by using incoherent undersampling and radial acquisition for clinical staging as well as quantitative analysis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| multi-parametric MRI | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- T-staging
- timeFrame
- 4 weeks after MR acquisition
- description
- T-staging of the tumor at MRI.
Secondary outcomes (10)
- measure
- N-staging
- timeFrame
- 4 weeks after MR acquisition
- description
- N-staging of the tumor at MRI
- measure
- arterial blood flow
- timeFrame
- 4 weeks after MR acquisition
- description
- arterial blood flow of the tumor and adjacent parenchma on DCE-MRI
- measure
- arterial fraction
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * surgical candidate for pancreatico-duodenectomy * characteristic finding of pancreatic adenocarcinoma on prior CT or MRI * OR histologically diagnosed with pancreatic adenocarcinoma * signed for informed consent Exclusion Criteria: * under 18 years * not eligible for pancreatico-duodenectomy * unresectable patients (locally advanced on prior CT/MRI or metastatic disease) * tumors with suspicion of other histologic types (neuroendocrine, IPMN, etc) * any contra-indication of contrast-enhanced MRI * recurred pancreatic cancer
References
Publications (0)
Data not yet available
No reference posted for this study.